Home
Astrid Olsnes Kittang's picture

Astrid Olsnes Kittang

Associate Professor
  • E-mailAstrid.Olsnes.Kittang@uib.no
  • Phone+47 55 58 54 11
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Azrakhsh, Nessar Ahmad; Mensah-Glanowska, Patrycja; Sand, Kristoffer; Kittang, Astrid Marta Olsnes. 2019. Targeting immune signaling pathways in clonal hematopoiesis. Current Medicinal Chemistry. 5262-5277.
  • Norberg, Anna; Rosén, Anna; Raaschou-Jensen, Klas; Kjeldsen, Lars; Moilanen, Jukka S.; Paulsson-Karlsson, Ylva; Baliakas, Panagiotis; Lohi, Olli; Ahmed, Aymen B; Kittang, Astrid Marta Olsnes; Larsson, Pär; Roos, Göran; Degerman, Sofie; Hultdin, Magnus. 2018. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders. European Journal of Human Genetics. 858-867.
  • Kittang, Astrid Marta Olsnes; Sand, Kristoffer; Brenner, Annette; Rye, Kristin Paulsen; Bruserud, Øystein. 2016. The systemic profile of soluble immune mediators in patients with myelodysplastic syndromes. International Journal of Molecular Sciences.
  • Sand, Kristoffer; Theorell, Jakob; Bruserud, Øystein; Bryceson, Yenan; Kittang, Astrid Marta Olsnes. 2016. Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes. Cancer Immunology and Immunotherapy. 1135-1137.
  • Kittang, Astrid Marta Olsnes; Kordasti, Shahram; Sand, Kristoffer; Costantini, Benedetta; Kramer, Anne Marijn; Perezabellan, Pilar; Seidl, Thomas; Rye, Kristin Paulsen; Hagen, Karen Marie; Kulasekararaj, Austin; Bruserud, Øystein; Mufti, Ghulam J. 2016. Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome. Oncoimmunology.
  • Jonsson, Maria Karolina; Hammenfors, Daniel; Oppegaard, Oddvar; Bruserud, Øystein; Kittang, Astrid Marta Olsnes. 2015. A 35-year-old woman with influenza A-associated thrombotic thrombocytopenic purpura. Blood Coagulation and Fibrinolysis. 469-472.
  • Tobiasson, Magnus; Dybedal, Ingunn; Holm, Mette Skov; Karimi, Mohsen; Brandefors, Lena; Garelius, Hege; Grövdal, Michael; Høgh-Dufva, Inge; Grønbæk, Kirsten; Jansson, Monika; Marcher, Vlaus Werenberg; Nilsson, Lars Håkan; Kittang, Astrid Marta Olsnes; Porwit, Anna; Saft, Leonie; Möllgård, Lars; Hellström-Lindberg, Eva. 2014. Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial. Blood Cancer Journal.
  • Fredly, Hanne Kristin; Ersvær, Elisabeth; Kittang, Astrid Marta Olsnes; Tsykunova, Galina; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2013. The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia. Clinical Epigenetics.
  • Reikvam, Håkon; Kittang, Astrid Marta Olsnes; Melve, Guro Kristin; Mosevoll, Knut Anders; Bentsen, Pål Tore; Ersvær, Elisabeth; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2013. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions? Current Cancer Drug Targets. 30-47.
  • Sand, Kristoffer; Rye, Kristin Paulsen; Mannsåker, Bård; Bruserud, Øystein; Kittang, Astrid Marta Olsnes. 2013. Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients. Oncoimmunology. 11 pages.
  • Reikvam, Håkon; Hatfield, Kimberley Joanne; Lassalle, Philippe; Kittang, Astrid Marta Olsnes; Ersvær, Elisabeth; Bruserud, Øystein. 2010. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. Expert Opinion on Investigational Drugs. 169-183.
  • Reikvam, Håkon; Hatfield, Kimberley Joanne; Øyan, Anne Margrete; Kalland, Karl-Henning; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2010. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. European Journal of Haematology. 239-251.
  • Olsnes, Astrid Marta; Ersvær, Elisabeth; Ryningen, Anita; Paulsen, Kristin; Hampson, Peter; Lord, Janet M.; Gjertsen, Bjørn Tore; Kristoffersen, Einar Klæboe; Bruserud, Øystein. 2009. The protein kinase C agonist PEP005 increases NF-kB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells. British Journal of Haematology. 761-774.
  • Olsnes, Astrid Marta; Hatfield, Kimberley Joanne; Bruserud, Øystein. 2009. The chemokine system and its contribution to leukemogenesis and treatment responsiveness in patients with acute myeloid leukemia. Balkan Union of Oncology. Journal. S131-S140.
  • Reikvam, Håkon; Hatfield, Kimberley Joanne; Øyan, Anne Margrete; Kalland, Karl-Henning; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2009. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors; release profile and pharmacological modulaion. European Journal of Haematology. 239-251.
  • Reikvam, Håkon; Olsnes, Astrid Marta; Gjertsen, Bjørn Tore; Ersvær, Elisabeth; Bruserud, Øystein. 2009. Nuclear Factor-kappaB Signaling: A Contributor in Leukemogenesis and a Target for Pharmacological Intervention in Human Acute Myelogenous Leukemia. Critical reviews in oncogenesis. 1-41.
  • Olsnes, Astrid Marta; Ryningen, Anita; Ersvær, Elisabeth; Bruserud, Øystein. 2008. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22. Journal of Interferon and Cytokine Research. 297-310.
  • Ersvær, Elisabeth; Olsnes, Astrid Marta; Bruserud, Øystein. 2007. The Immunological Dilemma: Cellular Innate and Adaptive Immune Response Versus Human Acute Myeloid Leukemia. The Open Hematology Journal. 1-14.
  • Bruserud, Øystein; Ryningen, Anita; Olsnes, Astrid Marta; Stordrange, Laila; Øyan, Anne Margrete; Kalland, Karl-Henning; Gjertsen, Bjørn Tore. 2007. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica. 332-341.
  • Ersvær, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet Martin; Olsnes, Astrid Marta; Ånensen, Nina; Tan, Eng M.; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2007. Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. European Journal of Haematology. 210-225.
  • Olsnes, Astrid Marta; Motorin, Dmitri ; Ryningen, Anita; Zaritskey, Andrey Y.; Bruserud, Øystein. 2006. T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC). Cancer Immunology and Immunotherapy. 830-840.
Doctoral dissertation
  • Sand, Kristoffer. 2015. Immunological aspects of myelodysplastic syndromes.
  • Kittang, Astrid Marta Olsnes. 2008. The chemokine system in acute myelogenous leukemia.
Abstract
  • Sand, Kristoffer Evebø; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2010. Circulating T Cells Derived From Patients with Low Risk Myelodysplastic Syndromes Show Altered Chemokine Receptor Expression. Blood. 1637-1638.
  • Reikvam, Håkon; Hatfield, Kimberley Joanne; Olsnes, Astrid Marta; Øyan, Anne Margrete; Kalland, Karl-Henning; Bruserud, Øystein. 2009. PRIMARY HUMAN ACUTE MYELOGENOUS LEUKEMIA CELLS SHOW CONSTITUTIVE RELEASE OF SEVERAL MATRIX METALLOPROTEASES AND THEIR INHIBITORS. Haematologica. 545-545.
  • Olsnes, Astrid Marta; Ersvær, Elisabeth; Ryningen, Anita; Bruserud, Øystein. 2008. Chemokine receptor expression by circulating T cells derived from acute leukemia patients with severe chemotherapy-induced cytopenia express a wide range of chemokine receptors. Haematologica. 456-457.
  • Olsnes, Astrid Marta; Ersvær, Elisabeth; Ryningen, Anita; Hampson, Peter; Lord, Janet M.; Bruserud, Øystein. 2007. The protein kinase C activator PEP005 increases the chemokine release in native acute myelogenous leukemia (AML) blasts. Experimental Hematology. 87-87.
  • Olsnes, Astrid Marta; Ersvær, Elisabeth; Bruserud, Øystein. 2007. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts: The chemokine release profile of the AML dendritic cells depends on the experimental protocol. Haematologica. 485-485.
Academic literature review
  • Tobiasson, Magnus; Kittang, Astrid Marta Olsnes. 2019. Treatment of myelodysplastic syndrome in the era of next-generation sequencing. 1-22.
  • Reikvam, Håkon; Fredly, Hanne Kristin; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2013. The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine-the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation. 336-362.
  • Bruserud, Øystein; Reikvam, Håkon; Kittang, Astrid Marta Olsnes; Ahmed, Aymen B; Tvedt, Tor Henrik Anderson; Sjo, Malvin; Hatfield, Kimberley Joanne. 2012. High-dose etoposide in allogeneic stem cell transplantation. 765-782.
  • Melve, Guro Kristin; Ersvær, Elisabeth; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2011. The chemokine system. in allogeneic stem-cell transplantation: a possible therapeutic target? 563-576.
  • Reikvam, Håkon; Hatfield, Kimberley Joanne; Kittang, Astrid Marta Olsnes; Hovland, Randi; Bruserud, Øystein. 2011. Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications. 23 pages.
  • Bruserud, Øystein; Kittang, Astrid Marta Olsnes. 2010. The chemokine system in experimental and clinical hematology. 3-12.
  • Kittang, Astrid Marta Olsnes; Hatfield, Kimberley Joanne; Sand, Kristoffer Evebø; Reikvam, Håkon; Bruserud, Øystein. 2010. The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leukemogenesis and Therapeutic Implications. 149-172.
  • Bruserud, Øystein; Ersvær, Elisabeth; Olsnes, Astrid Marta; Gjertsen, Bjørn Tore. 2008. Anticancer Immunotherapy in Combination with Proapoptotic Therapy. 666-675.
  • Hatfield, Kimberley Joanne; Olsnes, Astrid Marta; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2005. Antiangiogenic therapy in acute myelogenous leukemia: Targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. 229-248.

More information in national current research information system (CRIStin)